Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Immuron Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 23.0K | 64.9K | +41.9K (+181.7%) |
| Value | $40.1K | $123.8K | +$83.7K (+208.7%) |
New holders (2)
Institutions that held Immuron Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 19,562 | $37.4K | 0.00% |
| XTX Topco Ltd | 17,968 | $34.3K | 0.00% |
Sold out (0)
Institutions that held Immuron Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
None.